Oppenheimer & Co’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-71,626
| Closed | -$2.24M | – | 1417 |
|
|
2018
Q1 | $2.24M | Hold |
71,626
| – | – | 0.06% | 366 |
|
|
2017
Q4 | $2.45M | Hold |
71,626
| – | – | 0.06% | 331 |
|
|
2017
Q3 | $2.3M | Sell |
71,626
-26,533
| -27% | -$851K | 0.06% | 354 |
|
|
2017
Q2 | $3.2M | Sell |
98,159
-590
| -0.6% | -$19.2K | 0.09% | 279 |
|
|
2017
Q1 | $3.11M | Sell |
98,749
-10,000
| -9% | -$315K | 0.09% | 275 |
|
|
2016
Q4 | $3.2M | Sell |
108,749
-30,000
| -22% | -$882K | 0.09% | 260 |
|
|
2016
Q3 | $4.01M | Sell |
138,749
-3,000
| -2% | -$86.8K | 0.12% | 200 |
|
|
2016
Q2 | $3.67M | Sell |
141,749
-5,000
| -3% | -$129K | 0.11% | 219 |
|
|
2016
Q1 | $3.64M | Buy |
146,749
+370
| +0.3% | +$9.17K | 0.11% | 210 |
|
|
2015
Q4 | $5.15M | Hold |
146,379
| – | – | 0.15% | 148 |
|
|
2015
Q3 | $3.1M | Buy |
146,379
+15,330
| +12% | +$324K | 0.09% | 246 |
|
|
2015
Q2 | $3.64M | Buy |
131,049
+64,556
| +97% | +$1.79M | 0.1% | 238 |
|
|
2015
Q1 | $2.03M | Buy |
66,493
+9,600
| +17% | +$293K | 0.06% | 392 |
|
|
2014
Q4 | $1.82M | Sell |
56,893
-7,000
| -11% | -$224K | 0.05% | 414 |
|
|
2014
Q3 | $1.81M | Sell |
63,893
-8,000
| -11% | -$226K | 0.05% | 409 |
|
|
2014
Q2 | $1.97M | Buy |
71,893
+11,478
| +19% | +$315K | 0.06% | 381 |
|
|
2014
Q1 | $1.59M | Buy |
60,415
+7,550
| +14% | +$199K | 0.05% | 444 |
|
|
2013
Q4 | $1.55M | Buy |
52,865
+14,880
| +39% | +$435K | 0.05% | 418 |
|
|
2013
Q3 | $1.16M | Buy |
37,985
+2,000
| +6% | +$61.2K | 0.04% | 482 |
|
|
2013
Q2 | $1.14M | Buy |
+35,985
| New | +$1.14M | 0.04% | 485 |
|